Age and time course of long-term motor and nonmotor complications in Parkinson disease
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 4, 2018
- Accepted in final form September 11, 2018
- First Published December 12, 2018.
Article Versions
- Previous version (December 12, 2018 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Stéphane Prange, MD,
- Teodor Danaila, MD,
- Chloé Laurencin, MD,
- Catherine Caire, CRA,
- Elise Metereau, PhD,
- Hélène Merle, CRA,
- Emmanuel Broussolle, MD, PhD,
- Delphine Maucort-Boulch, MD, PhD and
- Stéphane Thobois, MD, PhD
- Stéphane Prange, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Fondation pour la Recherche M?dicale (research grant FRM-FDM 40482); (2) France Parkinson
NONE
NONE
NONE
NONE
NONE
NONE
- Teodor Danaila, MD,
NONE
NONE
Abbvie
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
France Parkinson
NONE
NONE
NONE
NONE
NONE
NONE
- Chloé Laurencin, MD,
NONE
NONE
abbvie, funding for travel to a congress saint jude and homeperf funding for travel to a congress
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Catherine Caire, CRA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Elise Metereau, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hélène Merle, CRA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Emmanuel Broussolle, MD, PhD,
Served on the French scientific advisory boards for Schwarz Pharma (2002-2006), Eutherapy (2005), Boehringer- Ingelheim (2004-2011), GE-Health Care (2004-2007), Lundbeck (2009-on going), UCB Pharma (2010-on going) and Novartis Pharma (2005-2015), ABBVIE (2015-2018)
NONE
Received funding for a trip and congress registration from Novartis Pharma (2005, 2010, 2011, 2013), GSK (2009), Boehringer-Ingelheim (2006,2007,2008), TEVA (2013), Medtronic (2013),UCB (2018)
Serve as an editorial board member of European Neurology (2004-on going) and Revue Neurologique (Paris) (2009-on going)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Aguettantlaboratories
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Delphine Maucort-Boulch, MD, PhD and
(1) DSMB for the company Maat Pharma in the past 2 years
NONE
NONE
Nephrology Dialysis Transplantation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stéphane Thobois, MD, PhD
Commercial entity : Novartis
NONE
Non-Profit entity: Movement Disorders Society teaching courseProfit entity: TEVA,Zambon, Abbvie,Aguettant, Lundbeck, UCB, Novartis : Honoraria for speaking engagements, travel
European Journal of Neurology, associate editor, 2009-2012Journal of Neurodegenerative Diseases, associate editor, 2012-2017Movement Disorders: editor, 2015-2017
NONE
NONE
NONE
medtronic
NONE
NONE
NONE
Commercial entity: medtronic
(1) Sponsor/funding source, grant number(s), role, year(s):National PHRC 2014, Subthalamic nucleus deep brain stimulation for severe dystonia associated with Wilson?s disease. PI(2) ANR 2010, ANR-09-MNPS-018, Co-PI.
NONE
(1) 2011, Fondation pour la Recherche M?dicale, R?le de la dopamine et de la s?rotonine dans l?expression des signes non moteurs et des m?canismes de compensation au stade pr?coce de la maladie de parkinson. Co-PI(2) 2010, Association France Parkinson. Hypersexuality in Parkinson's disease: fMRI study. Co-PI(3) Fondation pour la recherche medicale. Thesis grant for stephane prange 2016(4) France Parkinson 2017. Role de la serotonine dans les troubles du controle des impulsions dans la maladie de Parkinson.
NONE
NONE
NONE
NONE
NONE
NONE
- From Université Lyon (S.P., T.D., C.L., E.M., E.B., S.T.), Institut des Sciences Cognitives–Marc Jeannerod, CNRS, UMR 5229, Bron; Hospices Civils de Lyon (S.P., T.D., C.C., C.L., E.M., H.M., E.B., S.T.), Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C, Centre Expert Parkinson, Bron; Université Lyon (C.L., E.B., D.M.-B., S.T.), Faculté de Médecine Lyon Sud Charles Mérieux, Oullins; Hospices Civils de Lyon (D.M.-B.), Service de Biostatistique, Lyon; and Université Lyon (D.M.-B.), Laboratoire de Biométrie et Biologie Évolutive, CNRS, UMR 5558, Pierre Benite, France.
- Correspondence
Dr. Prange stephane.prange{at}isc.cnrs.fr
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.